ubenimex has been researched along with docetaxel anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Huang, XE; Huo, JG; Li, CG; Li, Y; Xu, JW | 1 |
1 trial(s) available for ubenimex and docetaxel anhydrous
| Article | Year |
|---|---|
Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Capsules; Cisplatin; Docetaxel; Female; Hemoglobins; Humans; Killer Cells, Natural; Leucine; Leukocytes; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; T-Lymphocytes; Taxoids; Tegafur | 2011 |
1 other study(ies) available for ubenimex and docetaxel anhydrous
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |